Diabetes Therapy

@Diabetes_Ther

PubMed-indexed, rapid publication, peer reviewed journal. Publishing all scientifically sound research in . See also

Chester, England
springer.com/springer+healt…
Vrijeme pridruživanja: rujan 2017.
343 fotografije ili videozapisa Fotografije i videozapisi

Tweetovi

Blokirali ste korisnika/cu @Diabetes_Ther

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Diabetes_Ther

  1. Prikvačeni tweet
    1. stu 2019.

    Listen to our now European Association for the Study of 2019 Conference: Podcast Overview of the Conference - recorded live at the conference with and Listen and read the full transcript here:

    11 proslijeđenih tweetova 12 korisnika označava da im se sviđa
    Poništi
  2. prije 1 sat

    Efficacy of Added to Continuous Infusion (CSII) in Hospitalized Patients with

    1 proslijeđeni tweet 1 korisnik označava da mu se sviđa
    Poništi
  3. 3. velj

    Effectiveness of a Video-Based Program Compared to Usual Care in Improving and Other Parameters in Individuals with : An Open-Label Parallel Arm Randomized Control Trial (RCT)

    Poništi
  4. 3. velj

    Application of Models to Evaluate Risk in

    3 proslijeđena tweeta 3 korisnika označavaju da im se sviđa
    Poništi
  5. 3. velj

    Best Practices and Tools for Titrating Basal : Expert Opinion from an Panel via the Modified Consensus Method

    Poništi
  6. 31. sij

    Efficacy and Safety of Once-Weekly in Using : Exploratory Subgroup Analysis by Insulin Regimen

    Poništi
  7. 31. sij

    Association of A1c, 1,5-Anhydro-D-Glucitol and Glycated With Stress in Mellitus Patients: A Cross-Sectional Study

    1 proslijeđeni tweet 2 korisnika označavaju da im se sviđa
    Poništi
  8. 28. sij

    and of Treatment With New Analogues in : Nation-Wide Survey

    1 reply 1 proslijeđeni tweet 1 korisnik označava da mu se sviđa
    Poništi
  9. 27. sij

    Commissioned review published by Board Member John Doupis: -Based in

    1 proslijeđeni tweet 1 korisnik označava da mu se sviđa
    Poništi
  10. 24. sij

    The Effect of LM25 and LM50 on in Patients: Post Hoc Analysis of a Randomized Crossover Trial

    1 proslijeđeni tweet 1 korisnik označava da mu se sviđa
    Poništi
  11. 24. sij

    Consensus Report published in : A Practitioner's Toolkit for Motivation in with and Mellitus: Evidence-Based Recommendations from an International Expert Panel

    1 proslijeđeni tweet
    Poništi
  12. 20. sij

    Study Protocol for Pleiotropic and of Sodium–Glucose Cotransporter 2 Inhibitor Versus in With and Fatty

    2 proslijeđena tweeta 4 korisnika označavaju da im se sviđa
    Poništi
  13. 17. sij

    Available to read now: Cost of Before and After Initiating Dipeptidyl Peptidase-4 Inhibitor Treatment: A Longitudinal Study Using a Public Health Insurance Database

    Poništi
  14. 14. sij

    New post-marketing surveillance study explores the long-term safety and effectiveness of in patients with and renal dysfunction

    1 proslijeđeni tweet 2 korisnika označavaju da im se sviđa
    Poništi
  15. 10. sij

    Commentary to “Differential Effect of on on Patients Treated with 300 U/ml and Insulin Degludec” by Kawaguchi et al. Diabetes Therapy 2019.

    Poništi
  16. 10. sij

    The Short-Term Cost-Effectiveness of Once-Weekly Versus Once-Daily and Once-Weekly for the Treatment of with : A Cost of Control Analysis in Read the PLS below and the full article here

    1 proslijeđeni tweet 1 korisnik označava da mu se sviđa
    Poništi
  17. 10. sij

    Just published: Impact of Switching from Twice-Daily Basal to Once-Daily Insulin 300 U/mL in People with on Basal-Bolus Insulin: Phase 4 Study

    Poništi
  18. 8. sij

    Just published from our Editorial Board member Sanjay Kalra and his colleagues: Utility of in the of : Expert Opinion from an International Panel

    1 reply 3 proslijeđena tweeta 6 korisnika označava da im se sviđa
    Poništi
  19. 8. sij

    Adherence to , and Activity and the Associated Factors Amongst with

    Poništi
  20. 3. sij

    Clinical Inertia in Poorly Controlled Mellitus with : An Observational Retrospective Study

    1 proslijeđeni tweet 3 korisnika označavaju da im se sviđa
    Poništi
  21. 23. pro 2019.

    Just published, authored by the journals Editor-in-Chief - a summary of the current Renal Outcome Trials: Outcomes in : A of and Outcome Trials

    1 proslijeđeni tweet 1 korisnik označava da mu se sviđa
    Poništi

@Diabetes_Ther još nije objavio nijedan Tweet.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·